NCT00290836View on ClinicalTrials.gov

Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

August 31, 2007

Conditions
Control of Local Bleeding in Patients Undergoing Prostatectomy.
Interventions
DRUG

Human fibrinogen/thrombin and bovine aprotinin (TachoComb H)

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY

NCT00290836 - Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU) | Biotech Hunter | Biotech Hunter